Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats
RESEARCH ARTICLE
Transdifferentiation-Induced Neural Stem
Cells Promote Recovery of Middle Cerebral
Artery Stroke Rats
Hui Yao1,2☯, Mou Gao1,3☯, Jianhua Ma1,4, Maoying Zhang1,5, Shaowu Li6, Bingshan Wu4,
Xiaohu Nie1,5, Jiao Jiao7, Hao Zhao1,2, Shanshan Wang1,2, Yuanyuan Yang7,
Yesen Zhang1,4, Yilin Sun6, Max S. Wicha8, Alfred E. Chang8, Shaorong Gao7*, Qiao Li8*,
Ruxiang Xu1,2*
1 Affiliated Bayi Brain Hospital, General Hospital of Beijing Military Region, P.L.A, Beijing, 100700, PR
China, 2 Neurosurgery Institute of Beijing Military Region, Beijing, 100700, PR China, 3 The Third Military
Medical University, Chongqing, 400038, PR China, 4 Anhui Medical University, Hefei, 230032, PR China,
5 Southern Medical University, Guangzhou, 510515, PR China, 6 Beijing Tiantan Hospital, Beijing, 100050,
PR China, 7 National Institute of Biological Science, Beijing, 102206, PR China, 8 University of Michigan,
Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States f of America
☯ These authors contributed equally to this work.
* (RX); (QL); (SG)
OPEN ACCESS
Citation: Yao H, Gao M, Ma J, Zhang M, Li S, Wu B,
et al. (2015) Transdifferentiation-Induced Neural
Stem Cells Promote Recovery of Middle Cerebral
Artery Stroke Rats. PLoS ONE 10(9): e0137211.
doi:10.1371/journal.pone.0137211
Editor: Jinglu Ai, St Michael's Hospital, University of
Toronto, CANADA
Received: March 4, 2015
Accepted: August 14, 2015
Published: September 9, 2015
Copyright: © 2015 Yao et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Abstract
Induced neural stem cells (iNSCs) can be directly transdifferentiated from somatic cells.
One potential clinical application of the iNSCs is for nerve regeneration. However, it is
unknown whether iNSCs function in disease models. We produced transdifferentiated
iNSCs by conditional overexpressing Oct4, Sox2, Klf4, c-Mycin mouse embryonic fibroblasts. They expanded readily in vitro and expressed NSC mRNA profile and protein markers. These iNSCs differentiated into mature astrocytes, neurons and oligodendrocytes in
vitro. Importantly, they reduced lesion size, promoted the recovery of motor and sensory
function as well as metabolism status in middle cerebral artery stroke rats. These iNSCs
secreted nerve growth factors, which was associated with observed protection of neurons
from apoptosis. Furthermore, iNSCs migrated to and passed through the lesion in the cerebral cortex, where Tuj1+ neurons were detected. These findings have revealed the function
of transdifferentiated iNSCs in vivo, and thus provide experimental evidence to support the
development of personalized regenerative therapy for CNS diseases by using genetically
engineered autologous somatic cells.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by the China
Postdoctoral Science Foundation (2013M532138)
and Military Twelfth Five-Year Key Sci-Tech
Research Projects (Grant Nos. BWS11J002 and
BWS12J010). This work was also supported in part
by the Gillson Longenbaugh Foundation.
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
Neural stem cells (NSCs) promote recovery of neurological disease and show anti-inflammatory, glial scar-inhibitory, and anti-apoptotic effects with neuroprotective functions [1]. These
characters make the use of NSCs a promising strategy for the regeneration of damaged brain
tissues. However, generation of sufficient numbers of human adult NSCs in vitro has remained
to be a major limitation for the application of NSCs. With the implication of transdifferentiation reprogramming, however, large quantities of iNSCs can be produced [2,3].
PLOS ONE | DOI:10.1371/journal.pone.0137211 September 9, 2015
1 / 19
Transdifferentiation-Induced NSCs Recover Stroke Rats
Transdifferentiation is defined as direct reprogramming or conversion of one cell type to
another by passing the induction of pluripotent stem cells (iPSCs) [4–6]. This process can be
used to reprogram adult somatic cells into either adult stem cells or differentiated cells of
another germ layer [7–12]. Classic iPSC transcription factors in conjunction with other neural
progenitor cell (NPC)-specific factors or microRNA have been used to transdifferentiate
human or mouse somatic cells into iNSCs/iNPCs. [13–17] While transdifferentiated iNSCs can
now be derived from human somatic cells, which shows significant potential of cell therapy
using autologous grafts, it is not known whether iNSCs/iNPCs can function in vivo as NSCs,
and few studies have assessed the behavior of iNSCs after transplantation.
In this study, we produced transdifferentiation-induced NSC colonies by direct inducing
mouse embryonic fibroblasts (MEFs) with conditional expression of OSKM or Oct4, Sox2, and
Klf4 (OSK). These cells were readily expanded in vitro. When transplanted into the brains of
middle cerebral artery occlusion (MCAO) rats after surgery, the iNSCs significantly improved
the motor and sensory functions of the MCAO rats. Importantly, these iNSCs migrated
through the lesion region, confirming that they can play an important role in the recovery of
MCAO rats.
Materials and Methods
Method to get MEF cells
GFP/rtTA, OG2/rtTA MEFs were isolated from E13.5 embryos. OG2/rtTA embryos were generated by crossing of B6; CBA-Tg (Pou5f1-EGFP) 2Mnn/J mice and B6.Cg-Gt (ROSA) 26
Sortm1 (rtTA M2) Jae/J mice. GFP/rtTA embryos got from crossing of C57BL/6-Tg
(CAG-EGFP) 1Osb/J and B6.Cg-Gt (ROSA) 26 Sortm1 (rtTA M2) Jae/J mice. All of the three
transgenic mice strain bought from The Jackson Laboratory.
To get MEF cells, mice at E13.5 gestation were sacrificed by performing cervical dislocation.
Saturate mouse abdomen with alcohol, cut back the skin and peritoneal wall with sterile instruments. Then remove uterine horns and place them into sterile, disposable petri dish. Wash
uterine horns 3 times with 10ml PBS. Then cut open embryonic sacs and release embryos and
place them in fresh dish and wash 3 times with 10ml PBS. Mince tissue with curved dissecting
scissors into grain sized pieces for approximately 5–10 minutes. After that, add 2ml Trypsin
and mince for an additional few minutes until pieces are further reduced in size, then pipet the
cells vigorously up and down. Then place dish into incubator for 20–30 minutes. After removing the minced tissue from incubator, add about 20ml MEF Derivation Culture Media and
transfer contents to a sterile 50ml plastic conical tube. Rinse remaining tissue in the plate with
a few milliliters MEF Derivation Culture Media (DMEM, 10% FBS and Penicillin-Streptomycin). Transfer media to the 50ml conical tube. Place 10ml MEF Derivation Culture Media into
each T75 Flask. Transfer 5ml minced tissue (...truncated)